Interferon gamma concentration in diabetes mellitus and dyslipidemia patient
Article Sidebar
-
IFN-γ, diabetes mellitus, dyslipidemia
Abstract
Background: Patient with diabetes mellitus (DM) occurs chronic inflammation by characterized a decreased concentration of various cytokinin types. This causes changes in the body’s immunity so that can be easier in having an infection. One of the most important cytokines against infection is IFN-γ. This study aimed to determine IFN-γ concentration in DM and dyslipidemia patients.
Metode: An amount of 234 people who received treatment at the health center in Banda Aceh in 2019 were included in this study. From each respondent, 5 ml of blood was taken to check fasting blood glucose, triglycerides, high-density lipoproteins (HDL), and interferon-gamma (IFN-γ). Test of fasting blood glucose, triglycerides, HDL was carried out using the colorimetric enzymatic method. The IFN-γ protein concentration was examined using the sandwich enzyme-linked immunosorbent assay (ELISA) technique.
Result: IFN-γ concentration in the non-DM group was higher than in the DM group. There was a significant difference between the average IFN-γ concentration in the non-DM group compared with the DM group (p = 0.000). All DM patients had increased fasting blood glucose, most had hypertriglycerides, but HDL levels were normal. The fasting blood glucose group <126 mg / dl had a higher IFN-γ concentration than the group with fasting blood glucose levels ≥126 mg / dl. There was a significant difference in the concentration of IFN-γ between the two groups (p = 0.000). The group with triglyceride levels <150 mg / dl had lower IFN-γ levels than the group with triglyceride levels ≥ 150 mg / dl. There was a significant difference between the average IFN-γ concentration between those groups (p = 0.000). The fasting blood glucose levels ≥126 mg / dl and triglycerides levels ≥ 150 mg / dl had higher IFN-γ concentration than the group who had fasting blood glucose levels ≥126 mg / dl and triglycerides levels < 150 mg / dl.
Conclusion: There are differences in IFN-γ concentrations in people with DM, increased fasting blood glucose and dyslipidemia compared to normal people.
Keywords: IFN-γ, diabetes mellitus, dyslipidemia
Abstrak
Latar belakang: Penderita diabetes mellitus (DM) dan dyslipidemia mengalami inflamasi kronik yang ditandai dengan perubahan konsentrasi berbagai sitokin. Hal ini yang menyebabkan perubahan imunitas tubuh sehingga mudah mengalami infeksi. Salah satu sitokin yang paling berperan terhadap infeksi adalah interferon gamma (IFN-γ). Penelitian ini bertujuan untuk memeriksa konsentrasi IFN-γ pada penderita DM dan dislipidemia.
Metode: Sebanyak 234 orang yang melakukan pengobatan di puskesmas di Kota Banda Aceh pada tahun 2019 diikutsertakan dalam penelitian ini. Dari setiap responden dilakukan pengambilan darah sebanyak 5 ml untuk dilakukan pemeriksaan kadar gula darah puasa (KGD P), trigliserida, high density lipoprotein (HDL), dan inrferon- gamma (IFN-γ). Pemeriksaan KGD, trigliserida, HDL dilakukan dengan metode enzimatik kolorimetrik. Pemeriksaan konsentrasi protein IFN-γ menggunakan teknik sandwich Enzyme-linked immunosorbent assay (ELISA).
Hasil: Konsentrasi IFN-γ pada kelompok non-DM lebih tinggi dibandingkan dengan kelompok DM. Terdapat perbedaan bermakna antara rata-rata konsentrasi IFN-γ pada kelompok non-DM dibandingkan dengan kelompok DM (p=0,000). Semua penderita DM mengalami peningkatan KGD P, sebagian besar mengalami hipertrigliserida, namun kadar HDL normal. Pada kelompok KGD P <126 mg/dl memiliki konsentrasi IFN-γ yang lebih tinggi dibandingkan dengan kelompok dengan KGD P ≥126 mg/dl. Terdapat perbedaan bermakna perbedaan konsentrasi IFN-γ antar kedua kelompok tersebut (p=0,000). Kelompok dengan kadar trigliserida <150 mg/dl memiliki kadar IFN-γ lebih rendah dibandingkan dengan kelompok dengan kadar trigliserida ≥ 150 mg/dl. Terdapat perbedaan bermakna antara rata-rata konsentrasi konsentrasi IFN-γ antar kedua kelompok tersebut (p=0,000). Pada kelompok KGD P ≥126 mg/dl dan trigliserida ≥ 150 mg/dl memiliki kadar IFN-γ yang lebih tinggi dibandingkan dengan kelompok KGD P ≥126 mg/dl namun trigliserida <150 mg/dl. Terdapat perbedaan bermakna antara rata-rata konsentrasi konsentrasi IFN-γ antar kedua kelompok tersebut (p=0,000).
Kesimpulan: Terdapat perbedaan konsentrasi IFN-γ pada orang dengan DM, peningkatan KGD P dan dislipidemia dibandingkan dengan orang normal.
Kata kunci : IFN-γ, diabetes mellitus, dislipidemia.
Full text article
References
Karuranga S, Malanda B, Saeedi P, Salpea P. Title article?? IDF Diabetes Atlas. 2019. doi: 978-2-930229-87-4.
Badan Penelitian dan Pengembangan Kesehatan. Laporan Nasional Riskesdas 2018. Lembaga Penerbit Badan Litbangkes; 2019. Indonesian.
Ramadhan N, Hanum S. Kontrol glikemik pada penderita diabetes mellitus tipe 2 di puskesmas Jayabaru kota Banda Aceh. Sel J Penelit Kesehat. 2017;3(1):1-9. doi:10.22435/sel.v3i1.6376.1-9. Indonesian.
Arifin AY, Ernawati F, Prihartini M. Hubungan kadar glukosa darah terhadap peningkatan kadar lemak darah pada populasi studi kohor kecamatan Bogor Tengah 2018. J Biotek Medisian Indones. 2018;8(2):87-93. Indonesian.
Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: Oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants. 2019;8(3). doi:10.3390/antiox8030072
Baldeón LR, Weigelt K, De Wit H, et al. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients. PLoS One. 2014;9(12):1-16. doi:10.1371/journal.pone.0115209
Ferlita S, Yegiazaryan A, Noori N, et al. Type 2 diabetes mellitus and altered immune system leading to susceptibility to pathogens, especially mycobacterium tuberculosis. J Clin Med. 2019;8(12):2219. doi:10.3390/jcm8122219
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2019;16(5):442-9. doi:10.2174/1573399815666191024085838
Tan KS, Lee KO, Low KC, et al. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria. J Clin Invest. 2012;122(6):2289-300. doi:10.1172/JCI57817
Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184-223. doi:10.3390/ijms15046184
Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-γ): exploring its implications in infectious diseases. Biomol Concepts. 2018;9(1):64-79. doi:10.1515/bmc-2018-0007
Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One. 2011;6(5). doi:10.1371/journal.pone.0019105
Grunfeld C. Dyslipidemia and its treatment in HIV infection. Top HIV Med. 2010;18(3):112-8.
Choi GJ, Kim HM, Kang H. The potential role of dyslipidemia in covid-19 severity: an umbrella review of systematic reviews. J Lipid Atheroscler. 2020;9(3):435-48. doi:10.12997/jla.2020.9.3.435
Marissa N, Ramadhan N, Hanum S, Marlinda M, Fitria E, Nur A. Reduction of tumor necrosis factor-alpha and interferon-gamma concentration on tuberculosis with diabetes mellitus as a marker in decrease immune system. Asian J Pharm Clin Res. 2019;12(11):151-4.
Subiyono, Martsiningsih MA, Gabrela D. Gambaran kadar glukosa darah metode GOD-PAP (Glucose Oxsidase – Peroxidase Aminoantypirin) sampel serum dan plasma EDTA (Ethylen Diamin Terta Acetat). J Teknol Lab. 2016;5(1):45-48. Indonesian. https://www.teknolabjournal.com/index.php/Jtl/article/view/77
Moghadasian MH, Frohlich JJ, Scudamore CH. Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J Clin Pathol. 2002;55(11):859-61. doi:10.1136/jcp.55.11.859
Fardid R, Ghahramani P, Shirazi M, et al. Expression of transforming growth factor-beta and interferon gamma biomarkers after whole body gamma irradiation. J Cancer Res Ther. 2018;14(7):1525-34. doi:10.4103/jcrt.JCRT
Wahyuniati N. Perani interferon gamma pada infeksi mycobacterium tuberculosis. J Kedokt Syiah Kuala. 2017;17(2):126-32. doi:10.24815/jks.v17i2.8992. Indonesian.
Asadikaram G, Ram M, Izadi A, et al. The study of the serum level of IL-4, TGF-β, IFN-γ, and IL-6 in overweight patients with and without diabetes mellitus and hypertension. J Cell Biochem. 2019;120(3):4147-57. doi:10.1002/jcb.27700
Price CL, Hassi HOSA, English NR, Blakemore AIF, Stagg AJ, Knight SC. Methylglyoxal modulates immune responses: relevance to diabetes. J Cell Mol Med. 2010;14(6 B):1806-15. doi:10.1111/j.1582-4934.2009.00803.x
Lagman M, Ly J, Saing T, et al. Investigating the causes for decreased levels of glutathione in individuals with type II diabetes. PLoS One. 2015;10(3):1-19. doi:10.1371/journal.pone.0118436
Zukhri S. Hubungan antara lama menderita dan kadar gula darah dengan terjadinya ulkus pada penderita Diabetes Mellitus di RSUP DR. Soeradji Tirtonegoro Klaten. TRIAGE J ilmu keperawatan. 2013;7(1):10-10. doi:10.4135/9781412971980.n30. Indonesian.
Tanase DM, Gosav EM, Radu S, et al. Arterial hypertension and interleukins: potential therapeutic target or future diagnostic marker? Int J Hypertens. 2019;2019. doi:10.1155/2019/3159283
Mirhafez SR, Tajfard M, Avan A, et al. Association between serum cytokine concentrations and the presence of hypertriglyceridemia. Clin Biochem. 2016;49(10-11):750-5. doi:10.1016/j.clinbiochem.2016.03.009
Okopień B, Krysiak R, Kowalski J, et al. The effect of statins and fibrates on interferon-γ and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis. 2004;176(2):327-35. doi:10.1016/j.atherosclerosis.2004.05.009
Rocha VZ, Folco EJ, Sukhova G, et al. Interferon-γ, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res. 2008;103(5):467-76. doi:10.1161/CIRCRESAHA.108.177105
Mirhafez SR, Pasdar A, Avan A, et al. Cytokine and growth factor profiling in patients with the metabolic syndrome. Br J Nutr. 2015;113(12):1911-9. doi:10.1017/S0007114515001038
Li P, Zhao Y, Wu X, et al. Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res. 2012;40(4):1609-20. doi:10.1093/nar/gkr984
McGillicuddy FC, Chiquoine EH, Hinkle CC, et al. Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem. 2009;284(46):31936-44. doi:10.1074/jbc.M109.061655
González-Pacheco H, Amezcua-Guerra LM, Vazquez-Rangel A, et al. Levels of high-density lipoprotein cholesterol are associated with biomarkers of inflammation in patients with acute coronary syndrome. Am J Cardiol. 2015;116(11):1651-7. doi:10.1016/j.amjcard.2015.09.009
Purwanti NWNA, Jirna IN, Arjani IAMS. Analisis hubungan kadar gula darah puasa dengan kadar kolesterol high density lipoprotein (HDL) pada pasien diabetes mellitus tipe 2 di RSUP Sanglah. Meditary. 2016;4(1):65-72. Indonesian.
Benghalem I, Meziane W, Hadjidj Z, et al. High-density lipoprotein immunomodulates the functional activities of macrophage and cytokines produced during ex vivo macrophage-CD4+ T cell crosstalk at the recent-onset human type 1 diabetes. Cytokine. 2017;96:59-70. doi:10.1016/j.cyto.2017.03.001
Abdulrahman A, AL-Barzinji R. Estimation of interferon gamma and some inflammatory atherogenic biomarkers levels in obese coronary atherosclerotic patients. Zanco J Med Sci. 2020;24(2):205-212. doi:10.15218/zjms.2020.024